News and Updates

Fear of Hypoglycemia is a real thing. Learn how you and your loved ones with T1D can overcome it.

The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics, from beta cell replacement to regeneration and glucose and complications trials, all with the result to change things for the type 1 diabetes (T1D) community. Here are Drs. Emily Sims, Jay Skyler, Marian Rewers and […]

On June 15, 2020, Abbott announced that the FDA has authorized the FreeStyle Libre 2 System. The Libre 2 gained its CE Mark clearance in Europe late 2018 and is now authorized for adults and children 4 and up in the United States. The FreeStyle Libre 2 is a 14 day continuous glucose monitor (CGM) […]

Named for Breakthrough T1D Research Committee member Elizabeth Caswell, Institute will support diabetes research and development of life-changing diabetes therapies.

The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics, from beta cell replacement to regeneration and glucose and complications trials, all with the result to change things for the type 1 diabetes (T1D) community. Here is Dr. Chantal Mathieu to share her key takeaways […]

Last year, at the American Association for Diabetes (ADA) Scientific Sessions, a drug, called teplizumab, was able to significantly delay—for over two years—the onset of type 1 diabetes (T1D) in participants with a high risk of developing the disease. This was the first ever study in humans to show a delay in the onset of […]

The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics, from beta cell replacement to regeneration and glucose and complications trials, all with the result to change things for the type 1 diabetes (T1D) community. Here are Drs. Eric Triplett, Randi Streisand, Hubert Tse and […]

Scientists have uncovered a potential breakthrough in developing a faster acting insulin in an unusual place: snails. Now, Breakthrough T1D-funded researchers are using the molecular features of the snail insulin to create ultra-rapid insulins for people with type 1 diabetes (T1D) and have published their findings in . As discussed in last year’s blog, certain […]

At Breakthrough T1D, we are committed to funding the development of new therapies to keep people with type 1 diabetes (T1D) healthier, longer, until cures are found. We saw an incredible number of key advances that have both improved the lives of those living with the disease today and that have taken us so much […]

A historical account about a past initiative that would help pave the way for Breakthrough T1D’s future approach to identifying research priorities.